Literature DB >> 24103408

A rare case of axillobifemoral bypass graft infection caused by Helicobacter cinaedi.

Yoshihiro Suematsu1, Sei Morizumi2, Kenichi Okamura2, Mitsuhiro Kawata2.   

Abstract

Helicobacter cinaedi infection is rarely encountered in nonimmunocompromised patients. We report the case of an 85-year-old man who presented with axillobifemoral bypass graft infection caused by Helicobacter cinaedi. The patient was not immunocompromised. We successfully treated him by iliac stenting of the native iliac artery, with near-total removal of the infected graft. At present, 48 months later, the patient is doing well at home, with no evidence of infection. To the best of our knowledge, this is the first report of infection of a prosthetic graft caused by Helicobacter cinaedi.
Copyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24103408     DOI: 10.1016/j.jvs.2013.08.048

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

Review 1.  First case of bacteremia caused by Helicobacter cinaedi in a patient with liver cirrhosis: a case report and literature review.

Authors:  Kenya Kamimura; Daisuke Kumaki; Masashi Arita; Yuji Kobayashi; Ken-Ichi Mizuno; Fumiko Kusama; Megumi Kobayashi; Hiroyuki Abe; Yoshifumi Takahashi; Kohei Ogawa; Yoko Shinagawa; Manabu Takeuchi; Yuichi Sato; Hirokazu Kawai; Satoshi Yamagiwa; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2015-09-05

2.  Infected Abdominal Aortic Aneurysm with Helicobacter cinaedi.

Authors:  Kazuhiro Nishida; Takamasa Iwasawa; Atsushi Tamura; Alan T Lefor
Journal:  Case Rep Surg       Date:  2016-01-17

3.  Acquired Hemophilia A Presenting with Infectious Aortic Aneurysms Due to an Underlying Helicobacter cinaedi Infection.

Authors:  Anna Matsuoka; Yuya Sasaki; Ai Kubodera; Kiyohito Hayashi; Ryo Shimizu; Akira Toriihara; Akira Nakamura; Keiichi Furukawa; Hiroaki Tanaka
Journal:  Intern Med       Date:  2021-06-12       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.